Awarded the "Cancer Friendly Charity Seal" for the second time! Medical reveals the future prospects of "Chenyao Medical": connecting the treatment and life circle of 900,000 cancer patients
Neousys International Medical System was awarded the “Cancer Friendly Seal” at the “2023 Global Health Forum” and won the award again this year (2024), becoming a cancer-friendly hospital for the second consecutive year. Dr. Chen Yongren, founder of Neousys International Medical System and chairman of the Taiwan Society for Clinical Non-Invasive Cancer Treatment Research, said in an interview that cancer care has entered the era of big data and precision treatment, and should keep pace with the times and take whole-person care as the ultimate goal. Medical staff with caring responsibilities need to be more diligent at all times to catch up with the generational trend of constantly updated medical technology.
The most taboo thing in cancer treatment is “seeking medical attention in a hurry”! Neousys Medical builds patient confidence step by step
About 900,000 patients with cancer receive treatment in Taiwan every year. Dr. Chen Yongren said that Neousas Medical has continued to increase its service base in recent years and hopes to establish a more complete care network for patients with cancer. In the past, many patients heard the bad news about cancer and often sought medical treatment first. Call public welfare groups or foundations for help; recently, many cancer patients have gone directly to Chenyao Clinic for consultation and have great confidence in the treatment courses planned by the clinic.
“Our responsibility is to provide patients with a trustworthy medical environment to prevent cancer patients from being misled by false information!”
Dr. Chen Yongren reminded that the various cancer treatments spread in the market are exaggerated and untrue, which may often delay the opportunity for medical treatment and even affect the quality of life of cancer patients. Neousys Medical is committed to providing formal, standardized and traceable treatment models. In particular, cancer is still a serious disease and it is most unfavorable to seek medical treatment in a hurry. Cancer patients are urged to identify the source of information or directly consult professional medical staff.
Go all out and spend money to lose your life? Does regenerative medicine do more good than harm to cancer patients?
This year, Taiwan’s medical regulations ushered in major changes. The “Regenerative Medicine Act” and the “Regulations on the Administration of Regenerative Medical Preparations” were passed on the third reading. Cancer is regarded as a key application area of regenerative medical technology. However, Dr. Chen Yongren pointed out that the practical application of the special management method may limit the choices of patients with cancer, and the cost of treatment is high. Without a more complete and personalized assessment, many people will end up “paying for their lives” even if they have the budget. The results are still not as expected.
“Cancer treatment is relatively more complicated than other diseases. It is not as simple as lung cancer patients undergoing CIK (cell therapy) or pancreatic cancer patients undergoing Gamma-Delta T (cell therapy). Cancer patients under the special control law have to undergo treatment every day. On average, only one case is put into treatment! In addition to being ineffective, it may also cause a loss of people and money!”
Dr. Chen Yongren explained that for patients with lung cancer, if CIK treatment is ineffective, they can turn to NK cell therapy for assistance. In fact, the benefits outweigh the risks. Neousys Medical has assisted many patients with comprehensive immune analysis and targeted different types of cancer, providing the most suitable cell therapy program to improve the accuracy and effectiveness of treatment.
Is CTC detection highly effective and difficult to promote? Not only is it expensive, “this reason” is also the key
Cancer detection has become popular in recent years. Dr. Chen Yongren said that circulating tumor cells (CTC) have been developed for more than 15 years and are non-invasive cancer monitoring methods. They can timely track the changes of cancer cells in patients and help predict the risk of recurrence. It is also an important tool for treatment. Reference indicators for effectiveness. However, CTC testing is expensive, and many cancer patients are deterred because they cannot afford the cost.
In order to improve the treatment rights of cancer patients, Neousys Medical believes that it should launch a more cost-effective testing solution that can help more patients. Dr. Chen Yongren emphasized that CTC testing is very practical for doctors, but its promotion efforts are always limited. The reason behind this is that many Taiwanese people prefer to choose folk remedies or health products with doubtful effects instead of examination items with scientific evidence, which is quite disappointing. regret.
In addition, Dr. Chen Yongren believes that the existing Western medicine treatment model tends to be “SOP”-based and may not meet the needs of cancer patients. Therefore, the timing of pre-cancer examination and the choice of treatment methods have become the key to affecting the effectiveness of treatment. For example, CTC detection not only quantifies tumor status, but can also be combined with quality analysis to comprehensively assess its malignancy and metastasis risk. One of Neousys Medical’s future prospects is to promote cancer friendliness and benefit cancer patients with more economical solutions.
From “Anti-Aging” to “Healthy Aging” The Importance and Practice of Preventive Medicine
Taiwanese people’s health awareness is on the rise, and preventive medicine is gradually receiving more attention. Dr. Chen Yongren pointed out that preventive medicine has changed from “anti-aging” in the past to “healthy aging”. The specific practices include being able to move (moderate exercise), eating (healthy diet) and meeting Sleeping (normal schedule) and early intervention after the disease is discovered are also crucial.
However, the traditional care model relies more on drugs and may not be able to solve the core problems of patients. Dr. Chen Yongren emphasized that modern people often have “difficult to treat” difficult and complicated diseases, and it is necessary to integrate professional doctors from various fields to provide assistance according to different causes of symptoms, especially for many patients who cannot receive effective treatment. Only through personalized care and advanced medical big data can preventive medicine be reduced to a slogan.
Dr. Chen Yongren gave an example. Neousys Medical assists patients to assess and adopt appropriate auxiliary therapies such as high-dose vitamin C treatment, whole-body hyperthermia and exercise prescriptions. Follow-up observations and follow-up have found that there is a significant effect in improving the condition. Dr. Chen Yongren emphasized that cancer treatment cannot only attack the tumor unilaterally, but more importantly, improve the microenvironment in the patient’s body to make the internal and external environment more conducive to recovery.
Extended reading: Promote charity and kindness to cancer patients! Zhu Xinyi attended the “2024 Global Health Industry Cross-Domain Forum” to reveal her anti-cancer journey
Awarded the “2024 Cancer Friendly Seal” Neousys Medical’s Future Outlook
Once again awarded the “Cancer Friendly Seal”, Dr. Chen Yongren said that Neousys Medical has helped countless cancer patients so far, especially prostate cancer and breast cancer, which are the most common and the results are remarkable. The successful cases have also greatly encouraged medical staff and motivated them. They continue to be on the front lines of caring for patients.
“The team has been under a lot of pressure because we are dealing with life-and-death issues and may be the patient’s last hope!” Dr. Chen Yongren pointed out that Neoyao Medical provides standardized treatment and tracking tools to help franchise hospitals follow the process. care. In the future, we will continue to increase our base and promote various initiatives to contribute to the progress of the overall medical industry.
Dr. Chen Yongren also pointed out that Neousys Medical’s role is not only a medical institution, but also committed to leading the conceptual change in cancer treatment and helping more cancer patients regain hope. Winning the award is an affirmation of the entire team. Looking into the future, Dr. Chen Yongren emphasized that Neousys Medical will continue to be committed to providing the highest quality treatment and care to cancer patients, combining various cutting-edge treatment concepts to bring more breakthroughs and innovations.
